Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
NCT ID: NCT06226948
Last Updated: 2025-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2024-05-06
2024-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile-based Lifestyle Intervention in Women With Glucose Intolerance After Gestational Diabetes
NCT03559621
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
NCT01430221
Lifestyle Intervention in Individuals With Low or High Genetic Risk for Type 2 Diabetes
NCT02709057
VIDA Mobile Health Cardiovascular Prevention Program
NCT02431546
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
NCT06211868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group 1
Participants will use a continuous blood glucose monitoring and visualization of CVDs risk.
CGM
Participants will wear CGM monitors for 10 days.
Visualization
Enriched visualization of SCORE2 CVD risk.
Intervention group 2
Participants will use a continuous blood glucose monitoring.
CGM
Participants will wear CGM monitors for 10 days.
Intervention group 3
Participants will use a visualization of CVDs risk.
Visualization
Enriched visualization of SCORE2 CVD risk.
Control group
No intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CGM
Participants will wear CGM monitors for 10 days.
Visualization
Enriched visualization of SCORE2 CVD risk.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without serious disease progression
* at least one risk factor for CVDs
Exclusion Criteria
* with serious disease progression
* without risk factor for CVDs
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Maribor
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adrijana Svensek
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Health Sciences
Maribor, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Darviri C, Alexopoulos EC, Artemiadis AK, Tigani X, Kraniotou C, Darvyri P, Chrousos GP. The Healthy Lifestyle and Personal Control Questionnaire (HLPCQ): a novel tool for assessing self-empowerment through a constellation of daily activities. BMC Public Health. 2014 Sep 24;14:995. doi: 10.1186/1471-2458-14-995.
Related Links
Access external resources that provide additional context or updates about the study.
European Society of Cardiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05a/2I-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.